Ipsen at a glance

Innovation for

patient care

Press releases

10 October 2014

Ipsen announces positive results from phase III clinical study of Decapeptyl® (triptorelin pamoate) 11.25 mg administered by subcutaneous…

10 October 2014

Aymeric Le Chatelier joins Ipsen as Executive Vice President, Chief Financial Officer

YOU ARE ON IPSEN'S CORPORATE WEBSITE

The corporate website is governed by the International Federation of Pharmaceutical Manufacturers & Associations code of practice.
Certain information provided on this website may not be strictly in conformity with the French regulations on advertising.

> Close